KMT2A and osteoporosis: Finally, given the critical roles of the NFIB–MLL1 complex in the stemness and plasticity of MSCs as well as in osteogenic differentiation, it is tempting to speculate that the NFIB–MLL1 complex might be able to serve as a potential therapeutic target for MSCs-related diseases such as osteoporosis (4, 5).